Navigation Links
Avalon Pharmaceuticals Announces Positive Interim Results For,AVN944 Phase I Trial

ent samples which show a correlation of changes in gene expression in a dose dependent manner. Importantly, several of these markers display a durable, sustained stress response indicative of cancer cell death, particularly in cancer cells from AML patients. As dose levels increase the biomarkers reflect an even greater impact of AVN944 on the cancer cells. Direct markers of apoptosis are induced at these higher levels, including members of the Bcl2 gene family which play a critical role in programmed cell death. Additionally, the IMPDH enzyme is inhibited and GTP pools are also depleted for more sustained time periods in treated patients.

Potential Study Stratification Biomarker Data: Additionally we have identified a genetic signature, existing prior to drug exposure, which correlates strongly with disease stabilization in the first cycle of therapy. While still preliminary, based on a small patient sampling, this signature could be the foundation for future patient stratification strategies in phase II and III clinical trials.

Teleconference and Webcast: The company will host a conference call on Wednesday, June 20, 2007 at 8 a.m. Eastern Daylight Time to discuss the interim results of the AVN944 Phase I clinical trial. Interested investors, analysts, members of the media and the general public can listen to the call live over the Internet from the investor section of the company's Web site or by dialing the numbers listed below. A detailed PowerPoint presentation will accompany the webcast.

    Conference Call Details:


    Dial-In:           (800) 291-5365 (U.S.)

                       (617) 614-3922 (International)

                       Pass code:  74005634


    Webcast:           Please go to www.avalonrx.com, Investor Relations,

                       within 15 minutes prior to the call and select the

                       webcast link.  If listening by phone and viewing 
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Avalon Updates the AVN944 Phase I Hematologic Malignancies Trial
2. Avalon Pharmaceuticals to Present at the American Association for Cancer Research 2007 Annual Meeting
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
10. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
11. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
Post Your Comments:
(Date:9/30/2014)... and LONDON , Sept. 30, ... MediciGlobal Ltd. announces its major milestone: ... community which caters to patients, families and caregivers, was ... tests and evolving treatments for Alzheimer,s disease. It also ... daily postings. Alzheimer,s ranks as the leading ...
(Date:9/30/2014)... Calif. , Sept. 30, 2014 Headquartered ... (OTC: GWPC) is a diversified company comprised of several ... of advanced technology and the proven expertise of its ... health and wellness. WholeHealth Products, line of more than ... healthcare centers, and its more than 8 retail consumer ...
(Date:9/30/2014)... N.Y. , Sept. 30, 2014  Millennium ... Millennium Medical Devices, has executed a sales, marketing ... Florida based provider of ... Accountable Care Organizations (ACOs) and hospitals through a ... serves over 10,400 active Physician Purchasing Accounts that ...
Breaking Medicine Technology:MediciGlobal's Alzheimer's Community Reaches 200,000 likes and more than half a million weekly visitors 2MediciGlobal's Alzheimer's Community Reaches 200,000 likes and more than half a million weekly visitors 3MediciGlobal's Alzheimer's Community Reaches 200,000 likes and more than half a million weekly visitors 4WholeHealth Products Announces The Discovery Of The "Autism And Fragile X" Microwell And Rapid Diagnostic Test 2Millennium Healthcare Secures New Sales, Marketing and Distribution Agreement 2Millennium Healthcare Secures New Sales, Marketing and Distribution Agreement 3
(Date:9/30/2014)... (PRWEB) September 30, 2014 A group of ... to combat an epidemic that, left unchecked, could create a ... are not headed to Africa. John Rogers, the Executive Director ... North Korea to fight a disease most think mankind conquered ... some 80 years ago is on the comeback in several ...
(Date:9/30/2014)... 2014 Bifidobacteria, the primary bacteria found ... diet, and stress, so a high Bifido probiotic can ... Ultimate Flora™ Men’s Complete contains 90 Billion ... Bifidobacteria strains to support a healthy large intestine (colon) ... and 32 billion cultures from 7 Lactobacillus strains to ...
(Date:9/30/2014)... in reducing the stigma associated with seeking help for ... but more improvement is still needed, according to a ... the Defense Department and the Veterans Health Administration to ... not seek needed care for mental health problems. ... treatment as a way to reduce stigma, according to ...
(Date:9/30/2014)... September 30, 2014 Healthcare advocates, patient ... National Association of Health Advocacy Consultants (#NAHAC) fifth annual ... (#NAHAC14) to be held October 30th - Nov. 1st, ... at NAHAC14: Standards and Best Practices for the Field ... a profession, advocates have needed a set of standards ...
(Date:9/30/2014)... Healthpointe is proud to announce that ... and ankle reconstruction surgeries to assist patients with severe ... specializes in the diagnosis and treatment of sports medicine, ... also trained to perform advanced Foot and Ankle Reconstruction ... is also fluent in Spanish. , Reconstructive surgical procedures ...
Breaking Medicine News(10 mins):Health News:US Delegation Heads to North Korea to Combat Tuberculosis Epidemic 2Health News:ReNew Life Introduces Ultimate Flora™ Men’s Complete Probiotic 90 Billion—Comprehensive Probiotic Support Just for Men 2Health News:US military making progress reducing stigma tied to seeking help for mental illness 2Health News:US military making progress reducing stigma tied to seeking help for mental illness 3Health News:Fellowship-Trained and Board-Certified Orthopedic Specialist Now Performing Advanced Foot & Ankle Reconstruction Surgeries 2Health News:Fellowship-Trained and Board-Certified Orthopedic Specialist Now Performing Advanced Foot & Ankle Reconstruction Surgeries 3
... a leader,in the development and marketing of disposable ... announced today that,BSSI has been purchased by Linden ... to Microflex(R), BSSI also owns MicroActive Corporation and,FoodHandler(R), ... leading supplier,of health and safety barrier products to ...
... and special initiatives encourage smokers to say ,I Quit, at The ... ... There,s some,ash-kicking, going on at the BODY WORLDS exhibit. Lung Cancer ... California,s,6-session Ash Kickers Quit Smoking Class and BODY WORLDS, I Quit ...
... Americans Have No Long Term Care Plans, WASHINGTON, ... long term care has on American families, the U.S. ... resolution proclaiming its,support for national Long Term Care Awareness ... one of the nation,s leading providers of,individual long term ...
... raising goal for United Way of ... ... Company,(NYSE: LLY ) chairman and chief executive officer Sidney Taurel ... Lilly,s,commitment to the agency,s 2008 fundraising campaign. For the United Way ...
... researchers find , TUESDAY, Nov. 6 (HealthDay News) -- ... of preclinical cardiovascular disease, U.S researchers report.. , Researchers ... women (who were free of cardiovascular disease at the ... intima media thickness (cIMT), a measure of the ...
... a mother with Alzheimers disease appear to be at higher risk ... according to a new study by NYU School of Medicine researchers. ... in this weeks online edition of the Proceedings of the National ... among cognitively normal people who have a father, a mother, or ...
Cached Medicine News:Health News:Microflex(R) Corporation Acquired by Linden and Edgewater 2Health News:BODY WORLDS 2 & Breathe California Pair Up for Some 'Ash Kicking' 2Health News:BODY WORLDS 2 & Breathe California Pair Up for Some 'Ash Kicking' 3Health News:Congress Proclaims Support for Long Term Care Awareness Week; Recent Poll Shows Voters Want Long Term Care Included in Presidential Candidates' Healthcare Proposals 2Health News:Congress Proclaims Support for Long Term Care Awareness Week; Recent Poll Shows Voters Want Long Term Care Included in Presidential Candidates' Healthcare Proposals 3Health News:Lilly Contributes $10.8 Million to United Way Annual Campaign 2Health News:A maternal link to Alzheimer's disease 2Health News:A maternal link to Alzheimer's disease 3
For the quantitative in vitro determination of Alanine Aminotransferase (ALT) in serum and plasma....
For the quantitative in vitro determination of Alkaline Phosphatase in serum or plasma....
... Tm Bioscience introduces the Tag-It™ Cystic Fibrosis ... cystic fibrosis genotyping. With validated performance criteria, ... will provide superior mutation coverage for carrier ... to diagnosis in newborns. ,The Tag-It™ ...
The Tag-It™ Cystic Fibrosis ASR reagents can be used by high complexity CLIA approved laboratories for detection of up to 70 mutations and 6 variants (polymorphisms) in the cystic fibrosis tran...
Medicine Products: